Solvay gives presentation on medical polymers at China International Medical Device Regulatory Forum
Solvay Specialty Polymers announced that it will participate in the 4th China International Medical Device Regulatory Forum (CIMDR) from September 11-13 in Xian, China. In addition to exhibit at the event, the company’s Director of Global Regulatory Affairs will deliver a technical presentation on high performance medical polymers offered for use in implantable and non-implantable applications.
According to Solvay Specialty Polymers, Shawn Shorrock, Global Market Manager for Healthcare and Director of Global Regulatory Affairs of the company, will evaluate the key decision criteria utilized in selecting the appropriate plastic for a variety of end-use requirements and provide an in-depth discussion of the performance capabilities of specific grades. Mr. Shorrock is also the co-chairman of the conference's Orthopaedics and Surgical Devices Forum.
"We look forward to our participation in the CIMDR Forum because it provides an opportunity to examine new issues, exchange information, and directly communicate with medical device regulatory bodies across geographic regions," says Ms. Shorrock. "Our involvement demonstrates our strong commitment to the growing Chinese medical device market and helps us further support our customers."
Meanwhile, Dr. Maureen Reitman, a Principal and the Director of the Polymer Science and Materials Chemistry Practice at Exponent Inc, an international engineering and scientific consulting firm based in Menlo Park, California, the US, will give a structure-property overview on polyetheretherketone (PEEK) resin for medical device uses.
Dr. Reitman will discuss the similarities and differences in properties of commercially available PEEK resins used in the manufacture of medical devices with an emphasis on the effect of processing, synthetic route, and thermal history on their structure and properties.
"CIMDR provides an opportunity to speak to a global audience about the structure-property relationship of commercially available medical PEEK resins in a way that will not only increase their footprint in medical applications, but will also facilitate the adoption of these novel materials to highly specialized uses," says Dr. Reitman.
Solvay says this structure-property overview will offer broader perspective and a clear understanding of the expected performance of commercially-relevant PEEK resins.
The 4th China International Medical Device Regulatory Forum is organized by the China Center for Pharmaceutical International Exchange (CCPIE).
